Skip to main content

Table 1 Characteristics of patients/residents

From: Recognizing acute delirium as part of your routine [RADAR]: a validation study

 

Total (N = 193)

Patients = 142 (73.6%)

Residents = 51 (26.4%)

Variables [Missing]

N (%)

M (SD)

N (%)

M (SD)

N (%)

M (SD)

Age (yrs.)

 

80.8 (7.8)

 

79.1 (7.3)

 

85.5 (7.5)

Sex (female)

116 (60.1)

 

76 (53.5)

 

40 (78.4)

 

Diagnosis of dementia (yes)

41 (21.2)

 

5 (3.5)

 

36 (70.6)

 

Types of dementia

      

 Not specified

3 (7.3)

 

1 (20.0)

 

2 (5.6)

 

 Alzheimer

12 (29.3)

 

1 (20.0)

 

11 (30.6)

 

 Vascular

4 (9.8)

 

2 (40,0)

 

2 (5.6)

 

 Mixed

19 (46.3)

 

1 (20.0)

 

18 (50.0)

 

 Korsakoff

3 (7.3)

   

3 (8.3)

 

DSM-IV-TR delirium

23 (12)

 

21 (14.8)

 

2 (3.9)

 

Severity of cognitive impairment (HDS) [1]

 

162.4 (50.9)

 

178.6 (32.0)

 

117.5 (65.0)

 Mild (≥160)

142 (74.0)

 

123 (87.2)

 

19 (37.3)

 

 Moderate (between 40 and 160)

39 (20.3)

 

16 (11.4)

 

23 (45.1)

 

 Severe (≤40)

11 (5.7)

 

2 (1.4)

 

9 (17.7)

 

Level of functional autonomy (SMAF)

 

13.8 (11.6)

 

9.6 (8.8)

 

25.4 (10.7)

 Mild <29

169 (87.6)

 

138 (97.2)

 

31 (60.8)

 

 Moderate 29-40

19 (9.8)

 

4 (2.8)

 

15 (29.4)

 

 Severe >40

5 (2.6)

   

5 (9.8)

 

Level of comorbidity: (CCI)

 

6.1 (1.9)

 

5.8 (1.9)

 

6.8 (1.9)

 Severe ≥ 8

37 (19.2)

 

21 (14.8)

 

16 (31.2)

 

Number of medications/day

 

10.1 (3.9)

 

10.1 (3.8)

 

10.0 (4.3)

Number of distributions of meds/day

 

3.6 (0.7)

 

3.5 (0.7)

 

3.6 (0.6)

  1. M (SD): Mean (standard deviation); HDS: Hierarchic Dementia Scale; SMAF: Functional Autonomy Measurement System; CCI: Charlson Comorbidity Index.